skip navigation nih record
Vol. LXVII, No. 21
October 9, 2015
cover

previous story



Seen


Congressman’s Visit Shines Light on Potential Effects of Federal Shutdown

U.S. Rep. Chris Van Hollen (D-MD) dropped by NIH’s Clinical Research Center on Sept. 22 for a science briefing with researchers in the NCI Pediatric Oncology Branch, a meeting with a research participant and a roundtable discussion with several NIH staffers.

Following the visit, the congressman held a Q&A session with members of the media to draw attention to the harmful effects a potential federal government shutdown could have on the lives of NIH patients and research.

NIH director Dr. Francis Collins (l) hosts a roundtable discussion with Rep. Chris Van Hollen.
NIH director Dr. Francis Collins (l) hosts a roundtable discussion with Rep. Chris Van Hollen.
Dr. Rob Rivers (c), NIDDK program director in the Office of Minority Health Research Coordination, chats at a medical board room briefing with Van Hollen, along with (from l) Dr. Jean Chin of NIGMS, Peggy Brandt Hansberger and Ned Culhane of the NIH Office of Legislative Policy and Analysis, and Dr. Allison Wise of NHLBI.

Dr. Rob Rivers (c), NIDDK program director in the Office of Minority Health Research Coordination, chats at a medical board room briefing with Van Hollen, along with (from l) Dr. Jean Chin of NIGMS, Peggy Brandt Hansberger and Ned Culhane of the NIH Office of Legislative Policy and Analysis, and Dr. Allison Wise of NHLBI.


Dr. Lee Helman (r), acting director of NCI’s Center for Cancer Research and CCR scientific director for clinical research, leads Van Hollen (c) and Collins (l) on a brief tour of a clinic and playroom. NCI senior investigator Dr. Brigitte Widemann (c), head of the pharmacology and experimental therapeutics section in the Pediatric Oncology Branch, talks about her research at a briefing with Van Hollen.

Dr. Lee Helman (r), acting director of NCI’s Center for Cancer Research and CCR scientific director for clinical research, leads Van Hollen (c) and Collins (l) on a brief tour of a clinic and playroom.

NCI senior investigator Dr. Brigitte Widemann (c), head of the pharmacology and experimental therapeutics section in the Pediatric Oncology Branch, talks about her research at a briefing with Van Hollen.

Photos: Ernie Branson



back to top of page